Replaceability of Fluoroscopy and Ultrasound in the Evaluation of Hemidiaphragm Excursion
NCT ID: NCT04098939
Last Updated: 2024-12-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
42 participants
OBSERVATIONAL
2020-05-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
With this study, the investigators wish to investigate the validity of different ultrasound and radiological methods and compare them with inspiratory pressure measurements.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants
Participants undergoing ultrasound and fluoroscopy assessment of diaphragm excursion.
Diaphragm evaluation
Ultrasound and radiographic evaluation of diaphragm function
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diaphragm evaluation
Ultrasound and radiographic evaluation of diaphragm function
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* one of the following conditions:
* Healthy participants, control group
* Lung disease group.
* COPD or
* Ideopatic pulmonary fibrosis.
* Heart disease group.
Heart disease that lead to:
* heart transplantat or
* left ventricular assist device.
Exclusion Criteria
* Neuromuscular disease.
* Pleural effusion.
* Pneumothorax.
* In the healthy group: Significant comorbidity that affect heart og lung function (arterial hypertention, mild valve disease and COPD without symptoms are accepted).
* In the healthy group and in the lung disease group: Previous thorax surgery.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Søren H Skaarup
Role: STUDY_CHAIR
Aarhus University Hospital
Peter Juhl-Olsen
Role: STUDY_CHAIR
Aarhus University Hospital
Brian Løgstrup
Role: STUDY_CHAIR
Aarhus University Hospital
Thomas Birkelund
Role: STUDY_CHAIR
Aarhus University Hospital
Morten Bendixen
Role: STUDY_CHAIR
Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Søren Helbo Skaarup
Aarhus, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Diaphragm Study AUH
Identifier Type: -
Identifier Source: org_study_id